Recent Advances in Treatment for Benign Prostatic Hyperplasia

December 2015 in “ F1000Research ”

Simon van Rij, Peter Gilling

TLDR BPH treatments are improving with personalized medicine and better surgical options.

In 2015, treatment for benign prostatic hyperplasia (BPH) was advancing with personalized medicine, which tailored treatments to individual patient needs and genetic characteristics. Technological advancements in surgical treatments were reducing morbidity. The future of BPH treatments appeared promising, with several novel techniques undergoing clinical trials.

View this study on f1000research.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Persistent Sexual Dysfunction and Depression in Finasteride Users for Male Pattern Hair Loss: A Serious Concern or Red Herring?

10 citations , December 2014 in “PubMed”

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

research Reduced Levels of 5-Alpha Reductase 2 in Adult Prostate Tissue and Implications for BPH Therapy

39 citations , February 2011 in “The Prostate/The prostate”

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

1707 citations , December 2003 in “The New England Journal of Medicine”

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.